Page 45 - Bse Nse

UltraTech Q3 Preview: Analysts eye QoQ rise in sales, profit on rising vol

Cement major, UltraTech Cement is scheduled to deliver its December 2024 quarter results (Q3FY25) on Thursday, January 23, 2025

Stock Market Crash Highlights: Sensex sinks 1,235pts, Nifty ends at 23,024; broader indices bleed 2%

Stock Market Crash Highlights, January 21, 2025: Indian equities faced severe declines on Tuesday with the 30-share BSE Sensex crashing 1235.08 points or 1.60 per cent to settle at 75,838.36

Indoco Remedies drops 4% on weak Q3 performance; revenue falls 11% YoY

Indoco Remedies share dropped after the company reported a weak set of numbers in the December quarter of financial year 2025 (Q3FY25)

DEE Development surges 7% after increasing capacity of Gujarat facility

DEE Development Engineers share price jumped 7.20 per cent at Rs 322 a piece on the BSE in Tuesday's intraday trade

Venus Remedies share price surges 12% on renewal of EU GMP certification

The rise in Venus Remedies share price came after the company announced the renewal of its European GMP certification by Infarmed, the National Authority of Medicines and Health Products in Portugal

DEV IT share price zooms 7% after securing project from Gujarat Metro Rail

DEV Information Technology (IT) share price jumped 6.62 per cent at Rs 649.90 a piece on the BSE in Tuesday's intraday trade

This Mukul Agrawal portfolio stock surges 23% in 3 days; hits new high

Mukul Agrawal bought a 1.61% stake in KRN, against nil holding at the end of September quarter, as per the company's December quarter shareholding pattern data

Here's why Tata Technologies share was buzzing in trade on January 21

The uptick in the Tata Technologies share price came in anticipation of the December quarter of financial year 2025 (Q3FY25) results

Landmark Cars share price zooms 7% after deal with JSW MG Motor; details

Landmark Cars share price jumped 6.62 per cent at Rs 649.90 a piece on the BSE in Tuesday's intraday trade

Paytm falls 7% on profit booking post Q3 results; up 161% in past 6 months

Paytm's revenue rose 10.1% sequentially, due to an increase in GMV, a healthy growth in subscription revenues and an increase in revenues from distribution of financial services

AGI Greenpac share price soars 10% after Q3 results; profit jumps 35%

AGI Greenpac share price jumped 9.78 per cent at Rs 1,092.65 a piece on the BSE in Tuesday's intraday trade

Newgen Software slips 10% post Q3 results; stock down 22% in 4 days

The revenue growth moderation was due to a lower-than-expected revenue realisation from the India business

Sunteck Realty jumps 11% after stellar Q3 results; profit soars 537%

Sunteck Realty share price jumped 11.19 per cent at Rs 546 a piece on the BSE in Tuesday's intraday trade. This came after the company reported a considerable rise in its profit for the third quarter

Stocks to Watch, Jan 21: Zomato, Dixon Tech, MCX, Oberoi Realty, IDBI Bank

Stocks to watch on January 21, 2025: Dixon Technologies Q3 consolidated net profit soared 122.8 per cent to Rs 216.2 crore, compared to Rs 97.1 crore.

Dr Reddy's Labs Q3 Preview: Revlimid to dent US sales, profits may rise 12%

Indian pharmaceutical (IT) major, Dr Reddy's Laboratories, is scheduled to deliver its October-December quarterly earnings for the financial year 2024-25 (Q3FY25) on Thursday, January 23, 2025

Stock Market Highlights: Sensex adds 454 pts, Nifty ends near 23,350; banks, metals, financials lead

Stock Market Highlights, January 20, 2025: Indian markets closed on a positive note on Monday with the 30-share Sensex gaining 454 points or 0.59 per cent to settle at 77,378.91

Vedanta quotes higher for fifth straight trading day; surges 12% in 1 week

Vedanta's consolidated Ebitda is expected to increase to more than Rs 44,000-45,000 cr by the end of FY25 (Rs 36,455 cr in FY24), supported by favourable prices and cost reduction

Voda Idea stock tops Rs 10-mark after 16 weeks; chart say can rise more 23%

Vodafone Idea stock is expected to trade with a favourable bias in the near-term as long as the stock holds above Rs 9.50 - Rs 9.35 support zone, suggests the technical charts.

Zydus Life up 2% on USFDA nod for Phase II(b) clinical trial for Usnoflast

Zydus Life share rose after it received approval from USFDA to conduct Phase II(b) clinical trial for Usnoflast, a novel oral NLRP3 inflammasome inhibitor in patients with ALS

This smallcap defense stock has zoomed 60% in 1 month; nears record high

Shares of Apollo Micro Systems hit a 52-week high of Rs 150, as they rallied 14% on the BSE in Monday's intra-day trade amid heavy volumes on expectations of strong third quarter earnings